| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |